Zuojin Wan reverses cetuximab resistance in KRAS-mutant colorectal cancer via the NRF2-GCH1/CoQ and DHODH/CoQ axes. // Phytomedicine. – URL: https://www.sciencedirect.com/science/article/pii/S0944711326010810?dgcid=rss_sd_all
Zuojin Wan reverses cetuximab resistance in KRAS-mutant colorectal cancer via the NRF2-GCH1/CoQ and DHODH/CoQ axes. Phytomedicine. https://www.sciencedirect.com/science/article/pii/S0944711326010810?dgcid=rss_sd_all
“Zuojin Wan reverses cetuximab resistance in KRAS-mutant colorectal cancer via the NRF2-GCH1/CoQ and DHODH/CoQ axes.” Phytomedicine.
@article{article108438,
title = {Zuojin Wan reverses cetuximab resistance in KRAS-mutant colorectal cancer via the NRF2-GCH1/CoQ and DHODH/CoQ axes},
journal = {Phytomedicine},
url = {https://www.sciencedirect.com/science/article/pii/S0944711326010810?dgcid=rss_sd_all}
}
Publication date: 8 December 2026 Source: Molecular Therapy Nucleic Acids, Volume 37, Issue 4 Author(s): Madison A. Schaefer, Brandon Wilbanks, Irene K. Yan, Alexis M. Sosic, Julia Driscoll, Rory L. Smoot, Tushar Patel, L. James Maher,...